HealthcareServices

Global Pharma ADMET Testing Market Set for Strong Expansion, Reaching $19.27 Billion With 12.6% CAGR by 2030

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the pharma admet testing market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Pharma ADMET Testing Market in 2030?

The pharma admet testing market size has experienced substantial expansion in recent years. It is anticipated to increase from $10.7 billion in 2025 to $11.99 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.1%. The upward trend observed historically can be attributed to various elements, including escalating pharmaceutical r&d investments, the broadening requirements for preclinical drug testing, the increasing complexity of drug molecules, a heightened regulatory emphasis on safety profiling, and the availability of advanced laboratory technologies.

The pharma admet testing market is poised for significant expansion in the coming years. It is projected to reach $19.27 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.6%. This growth throughout the forecast period is driven by factors such as the escalating demand for cost-efficient drug development, the increasing adoption of predictive ADMET analytics, the expansion of personalized medicine pipelines, the growing integration of machine learning in drug testing, and a rise in the outsourcing of ADMET testing services. Major trends anticipated during this period include a broader uptake of in silico ADMET modeling tools, an increased utilization of high-throughput screening technologies, the development of AI-based toxicity prediction platforms, a greater incorporation of omics data in drug testing, and a sharpened focus on early-stage drug safety evaluation.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12024&type=smp

What Drivers Are Influencing Production Trends In The Pharma ADMET Testing Market?

An anticipated rise in the number of clinical trials is projected to propel the expansion of the pharma ADMET testing market in the future. A clinical trial represents a scientific investigation involving human subjects, primarily aimed at assessing the safety, effectiveness, and possible adverse reactions of a medical intervention, including novel drugs, medical devices, diagnostic methods, or therapeutic approaches. This surge in clinical trials significantly heightens the requirement for comprehensive evaluations of drug safety and efficacy within the pharma ADMET testing market, underscoring the vital importance of customized assessments for various drug candidates and patient demographics. For instance, data from December 2024, as reported by the Association of the British Pharmaceutical Industry, a UK-based nonprofit organization, indicated that industry-initiated clinical trials in the UK expanded from 411 trials in 2022 to 426 trials in 2023, which constitutes a 3.7% increase. Consequently, the observed growth in clinical trials is a primary driver for the development of the pharma ADMET testing market.

Which Segment Groups Are Influencing The Pharma ADMET Testing Market?

The pharma admet testing market covered in this report is segmented –

1) By Testing Type: In Vivo ADMET Testing, In Vitro ADMET Testing, In Silico ADMET Testing

2) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology

3) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications

Subsegments:

1) By In Vivo ADMET Testing: Animal Studies, Pharmacokinetics Studies, Toxicology Studies, Biodistribution Studies

2) By In Vitro ADMET Testing: Metabolism Studies, Drug-Drug Interaction Studies, Absorption Studies, Cytotoxicity And Safety Testing

3) By In Silico ADMET Testing: Predictive Modeling and Simulation, Quantitative Structure-Activity Relationship (QSAR) Analysis, Machine Learning Algorithms For ADMET Predictions, Software Tools For ADMET Profiling

Which Trends Are Guiding The Evolution Of The Pharma ADMET Testing Market?

Leading companies in the pharma ADMET testing market are bringing in innovative products, including artificial intelligence-driven drug design, which allows for the automated creation of novel small molecule structures from the ground up. Artificial intelligence-driven drug design refers to the application of artificial intelligence (AI) to design and optimize drug molecules without relying exclusively on traditional lab-based screening or manual medicinal chemistry. For example, in June 2025, Simulations Plus Inc., a US-based firm specializing in cheminformatics software for the pharmaceutical sector, launched ADMET Predictor 13. This is an advanced artificial intelligence-driven platform for drug design and ADMET prediction, which integrates enhanced high-throughput PBPK simulations and a generative AI-enabled drug-design engine (AIDD). Additionally, it offers optimized workflows that enable faster and more informed decision-making in drug development.

Who Are The Core Companies Influencing Trends In The Pharma ADMET Testing Market?

Major companies operating in the pharma admet testing market are Thermo Fisher Scientific Inc., The Merck Group, Laboratory Corporation of America Holdings, IQVIA Inc., PPD ICON plc, Agilent Technologies Inc., Wuxi AppTec Co. Ltd., Catalent Inc., Covance Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Beckman Coulter Inc., Perkinelmer Inc., Albany Molecular Research Inc., Evotec A.G., CMIC Holdings Co. Ltd., Promega Corporation, Aptuit LLC, Symeres B.V., Biovia Corp., BioIVT LLC, Cyprotex Limited, InSphero AG, Admescope Ltd., Accelrys Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

Which Regions Are Projected To Dominate The Pharma ADMET Testing Market In The Coming Years?

Asia-Pacific was the largest region in the pharma ADMET testing market in 2025. The regions covered in the pharma admet testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pharma ADMET Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12024&type=smp

Browse Through More Reports Similar to the Global Pharma ADMET Testing Market 2026, By The Business Research Company

Software Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/software-testing-global-market-report

Adme Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Testing Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/testing-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795